Broad HIV-1 neutralization mediated by CD4-binding site antibodies (Q36977635)

17 August 2017

Broad HIV-1 neutralization mediated by CD4-binding site antibodies (English)

1 reference

17 August 2017

1 reference

11

John R Mascola

1 reference

17 August 2017

8

George M Shaw

1 reference

17 August 2017

10

Richard T Wyatt

1 reference

17 August 2017

6

Mark K Louder

1 reference

17 August 2017

Yuxing Li

1

1 reference

17 August 2017

Stephen A Migueles

2

1 reference

17 August 2017

Brent Welcher

3

1 reference

17 August 2017

Krisha Svehla

4

1 reference

17 August 2017

Adhuna Phogat

5

1 reference

17 August 2017

Xueling Wu

7

1 reference

17 August 2017

Mark Connors

9

1 reference

17 August 2017

language of work or name

English

0 references

publication date

26 August 2007

1 reference

17 August 2017

1 reference

17 August 2017

13

1 reference

17 August 2017

1032-1034

1 reference

17 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1624

17 August 2017

0 references

cites work

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Structural definition of a conserved neutralization epitope on HIV-1 gp120

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

The antigenic structure of the HIV gp120 envelope glycoprotein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

HIV vaccine design and the neutralizing antibody problem

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584972

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17721546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM1624

1 reference

17 August 2017

1 reference

17 August 2017

1 reference